Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Tanaka

Showing results (201-210 of 217) with videos related to

Pageof 22
Sort By:
Journal for Immunotherapy of Cancer|February 9, 2024
Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancerShogo Takei, Yosuke Tanaka, Yi-Tzu Lin, et al.
Nature Communications|December 21, 2019
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutationsSatoshi Inoue, Yasushi Hirota, Toshihide Ueno, et al.
Communications Biology|December 22, 2023
Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemiaEmi Sugimoto, Jingmei Li, Yasutaka Hayashi, et al.
Nature Communications|March 24, 2021
Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathwayTakeshi Fujino, Susumu Goyama, Yuki Sugiura, et al.
Blood|June 4, 2020
HHEX promotes myeloid transformation in cooperation with mutant ASXL1Reina Takeda, Shuhei Asada, Sung-Joon Park, et al.
Nature Cardiovascular Research|December 9, 2024
Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunityNaru Sato, Susumu Goyama, Yu-Hsuan Chang, et al.
Journal of Biochemistry|November 22, 2015
Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD)Toshio Kitamura, Naoko Watanabe-Okochi, Yutaka Enomoto, et al.
Elife|October 22, 2024
Correction: Context-dependent modification of PFKFB3 in hematopoietic stem cells promotes anaerobic glycolysis and ensures stress hematopoiesisShintaro Watanuki, Hiroshi Kobayashi, Yuki Sugiura, et al.
Nature Cancer|February 19, 2025
Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802)Hideaki Bando, Shogo Kumagai, Daisuke Kotani, et al.
Elife|April 4, 2024
Context-dependent modification of PFKFB3 in hematopoietic stem cells promotes anaerobic glycolysis and ensures stress hematopoiesisShintaro Watanuki, Hiroshi Kobayashi, Yuki Sugiura, et al.
Pageof 22

Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Journal for Immunotherapy of Cancer|February 9, 2024
Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancerShogo Takei, Yosuke Tanaka, Yi-Tzu Lin, et al.
Nature Communications|December 21, 2019
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutationsSatoshi Inoue, Yasushi Hirota, Toshihide Ueno, et al.
Communications Biology|December 22, 2023
Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemiaEmi Sugimoto, Jingmei Li, Yasutaka Hayashi, et al.
Nature Communications|March 24, 2021
Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathwayTakeshi Fujino, Susumu Goyama, Yuki Sugiura, et al.
Blood|June 4, 2020
HHEX promotes myeloid transformation in cooperation with mutant ASXL1Reina Takeda, Shuhei Asada, Sung-Joon Park, et al.
Nature Cardiovascular Research|December 9, 2024
Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunityNaru Sato, Susumu Goyama, Yu-Hsuan Chang, et al.
Journal of Biochemistry|November 22, 2015
Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD)Toshio Kitamura, Naoko Watanabe-Okochi, Yutaka Enomoto, et al.
Elife|October 22, 2024
Correction: Context-dependent modification of PFKFB3 in hematopoietic stem cells promotes anaerobic glycolysis and ensures stress hematopoiesisShintaro Watanuki, Hiroshi Kobayashi, Yuki Sugiura, et al.
Nature Cancer|February 19, 2025
Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802)Hideaki Bando, Shogo Kumagai, Daisuke Kotani, et al.
Elife|April 4, 2024
Context-dependent modification of PFKFB3 in hematopoietic stem cells promotes anaerobic glycolysis and ensures stress hematopoiesisShintaro Watanuki, Hiroshi Kobayashi, Yuki Sugiura, et al.
Pageof 22